» Articles » PMID: 25281874

Synthesis of Tat Tagged and Folate Modified N-succinyl-chitosan Self-assembly Nanoparticles As a Novel Gene Vector

Overview
Publisher Elsevier
Date 2014 Oct 5
PMID 25281874
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this research was to prepare a novel type of Tat tagged and folate modified N-succinyl-chitosan (Tat-Suc-FA) self-assembly nanoparticles, to provide a new vector for tumor gene therapy. In this study, Tat-Suc-FA polymers was synthesized and characterized using (1)H NMR and FT-IR. The copolymer had a mean diameter of 65 ± 22.6 nm, a zeta potential of 40 ± 0.2 mV. The cytotoxicity assay showed that Tat-Suc-FA polymers were less toxic than chitosan in the tested concentration range (from 2 to 500 μg/ml). Tat-Suc-FA/DNA complexes at various weight ratios were formulated and characterized. Particle sizes of Tat-Suc-FA/DNA complexes were between 54 and 106 nm as determined by dynamic light scattering. Accordingly, Transmission electron microscope photo of Tat-Suc-FA/DNA complexes exhibited a spherical and compact morphology. Zeta potentials of these complexes changed as the weight ratio varied (from 3 to 44 mV). Agarose gel electrophoresis assay showed that Tat-Suc-FA could efficiently condense the DNA, when the weight ratio was above 1.5/1. Together, these results suggest that the low toxic Tat-Suc-FA cationic polymers could be considered for use as a novel type of gene delivery vectors.

Citing Articles

The Chemical Modification to Improve Solubility of Chitosan and Its Derivatives Application, Preparation Method, Toxicity as a Nanoparticles.

Suryani S, Chaerunisaa A, Joni I, Ruslin R, Aspadiah V, Anton A Nanotechnol Sci Appl. 2024; 17:41-57.

PMID: 38469157 PMC: 10926861. DOI: 10.2147/NSA.S450026.


Modified Linear Peptides Effectively Silence STAT-3 in Breast Cancer and Ovarian Cancer Cell Lines.

Mandal D, Lohan S, Sajid M, Alhazza A, Tiwari R, Parang K Pharmaceutics. 2023; 15(2).

PMID: 36839988 PMC: 9962452. DOI: 10.3390/pharmaceutics15020666.


Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Sivanesan I, Tasneem S, Hasan N, Shin J, Muthu M, Gopal J Polymers (Basel). 2022; 14(11).

PMID: 35683804 PMC: 9182633. DOI: 10.3390/polym14112131.


Development of Covalent Chitosan-Polyethylenimine Derivatives as Gene Delivery Vehicle: Synthesis, Characterization, and Evaluation.

Nicolle L, Casper J, Willimann M, Journot C, Detampel P, Einfalt T Int J Mol Sci. 2021; 22(8).

PMID: 33917124 PMC: 8067803. DOI: 10.3390/ijms22083828.


Advances in intracellular delivery through supramolecular self-assembly of oligonucleotides and peptides.

Kim J, Narayana A, Patel S, Sahay G Theranostics. 2019; 9(11):3191-3212.

PMID: 31244949 PMC: 6567962. DOI: 10.7150/thno.33921.